Lung Cancer Prognosis, Lung Cancer Survival Rate

In addition to the customary lung cancer survival rate indicators, it is now possible to better gauage Lung Cancer Prognosis using a protein profile.

Vanderbilt University Medical Center researchers have identified a set of protein profiles (focusing on 15 proteins) that can be used to help determine the prognosis of a lung cancer patient.

The information obtained by the above mentioned protein profiling is considered to be very valuable in further developing the course of treatment for a lung cancer patient. For example, if the protien profile is suggestive of a good prognosis, attending physicians may decide to pursue an aggressive therapy right from an early stage of lung cancer. Contrarary to the above, if the proteni profile is indicative of a poor prognosis, the primary focus of the lung cancer treatment/care options may remain on improving the quality of life of such a (end stage lung cancer ) patient, rather than on agressive (and often painful) lung cancer therapies.

It has also been established that the above described protein profile helps predict -with a fairly reasonable accuracy -the possibilites of the cancer having spread to lymph nodes within the close proximity of the lung cancer site.

Vanderbilt University study shows that all patients who had received a poor lung cancer prognosis from the protein profile had died a year after diagnosis due to terminal, advanced lung cancer, while all patients in the good prognosis group were still alive at the time of pubishing of that report. The Median survival Point - the point at which half of the lung cancer patients were still alive - was found to be 33 months for the good prognosis group and six months for the poor prognosis group.

Additional information available on: Lung Cancer Causes, Lung Cancer Risk Factors, Lung Cancer Early Signs, Lung Cancer Symptoms, Lung Cancer Early Diagnosis, Staging of Lung Cancer Tumors, Lung Cancer Treatment, Lung Cancer Vaccine, Lung Cancer Prognosis, Small Cell Lung Cancer, - SCLC, Non-Small Cell Lung Cancer - NSCLC, Mixed Small Cell/Large Cell Lung Cancer, Asbestos, Asbestosis, Mesothelioma, Lung Cancer Caused by Asbestos Exposure, Pleural Mesothelioma, Peritoneal Mesothelioma, Pericardial Mesothelioma, Mesothelioma Diagnosis, Mesothelioma Symptoms, Mesothelioma Treatment, Mesothelioma Drugs, Mesothelioma Surgery, Mesothelioma Chemotherapy Drugs, and Mesothelioma Radiation Therapy.

Check out asbestos news for the latest asbestos lung disease news, and mesothelioma news.

Note: Consult a qualified medical practitioner if you suspect lung disease. Information published at this mesothelioma lung disease asbestos cancer forum - or most other websites for that matter - should not be relied upon for health decisions. The information presented on this web site is not intended as a substitute for medical care, medical, legal, or professional advise. Please talk with your healthcare provider for all your health concerns.